Critical Analysis of Look Alike and Sound Alike Branded Drug Names in Clinical Practice

Authors

  • Priyadarshini B. Department of OBG, Sapthagiri Institute of Medical Sciences, Bangalore, Karnataka, India
  • Nagabushan H. Department of Pharmacology, Mandya Institute of Medical Sciences, Mandya, Bangalore, Karnataka, India

Abstract

Look Alike and Sound Alike (LASA) drugs or confusing drug names are among the most common reasons for medication errors worldwide and the potential for confusion is significant because of presence of numerous drugs in the market. The purpose of this article is to analyze those LASA brand drug pair which could result in potential medication errors, if interchanged and also to suggest possible methods of reducing errors due to LASA. The recent issues of drug formularies such as Current Index of Medical Specialities (CIMS), Drug Today, RefRx, Indian Drug Review and others were used as source of data and all the potentially confusing brand drug names were analyzed and categorized into various groups. A total of 304 LASA brand drug pair names with different generic drug composition were analyzed. Most of the LASA brand drug pair started from alphabet “A”, and were antimicrobial agents.

 

Keywords: Look Alike and Sound Alike (LASA) drugs, brand names, Levenshtein distance (LD)

Cite this Article

Nagabushan H, Priyadarshini B. Critical Analysis of Look Alike and Sound Alike Branded Drug Names in Clinical Practice. Research & Reviews: A Journal of Pharmacology (RRJoP). 2016; 6(1): 4–9p.

Downloads

Published

2019-07-23

Issue

Vol. 6 No. 1 (2016)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.